GLP-1 'Ozempic Personality' Side Effect Emerges Clinically; Cycling Safety Unclear

Washington Times (April 30) and NPR (April 15) reported GLP-1 patients experiencing appetite, libido and social engagement decline—termed 'Ozempic personality'—with some cycling drug use on and off. Long-term safety and effects of cycling remain understudied.